CoreFirst Bank & Trust
- SEC CIK
- 0001845199
- Latest filing
- Aug 5, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by CoreFirst Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −203−100.0% | Sold out | Holders |
| Q4 2022 | 203 | $3.17K | <0.1% | −503−71.2% | Reduced | Holders |
| Q3 2022 | 706 | $9.00K | <0.1% | −190−21.2% | Reduced | Holders |
| Q2 2022 | 896 | $13.0K | <0.1% | −8,450−90.4% | Reduced | Holders |
| Q1 2022 | 9,346 | $134.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 9,346 | $128.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 9,346 | $154.0K | 0.1% | +4,173+80.7% | Added | Holders |
| Q2 2021 | 5,173 | $87.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 5,173 | $94.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.